nejm semaglutide ckd ❇️Patients with obesity, type 2 #diabetes and chronic kidney disease are at high risk for kidney failure, cardiovascular events, and death. This study, the FLOW trial now published, evaluated treatment with (# Chronic Kidney Disease | Ozempic®

Ozempic, also known as semaglutide, can aid weight loss

Metabolic health is highly dependent on intestinal and hepatic handling of dietary and endogenous lipids and lipoproteins

The This Is Us alum, 44, flaunted her slimmer figure in a short-sleeved, pastel yellow, blue and pink dress with a ...

Duori metabolism support patches fit into a daily wellness routine with clean wearable ingredients

Columbus, Ohio Where to Get GLP-1s in Columbus

Indications: Type 2 Diabetes Mellitus (monotherapy or add-on therapy) Especially useful in patients who cannot tolerate metformin or sulfonylureas Can be used in elderly and patients with mild renal impairment Approved Agents in India: Sitagliptin (Januvia) Vildagliptin (Galvus) Saxagliptin (Onglyza) Linagliptin (Trajenta) No renal dose adjustment needed Alogliptin (Nesina) Dosing: Once daily oral dosing Some agents require renal dose adjustment (except Linagliptin) Often combined with metformin or SGLT2 inhibitors Side Effects: Nasopharyngitis, headache GI upset (mild) Rare: Acute pancreatitis, severe joint pain, skin reactions Saxagliptin may slightly increase risk of heart failure in some patients Advantages Over Other Classes: Weight neutral Low risk of hypoglycemia Well tolerated in the elderly Convenient once-daily dosing Limitations: Modest HbA1c reduction (0.50.8%) Not effective in Type 1 Diabetes Less potent than GLP-1 analogs or SGLT2 inhibitors Conclusion: DPP-4 inhibitors are a safe, effective, and well-tolerated option for many patients with T2DM especially those needing an add-on to metformin or who can't tolerate injectables